The Valley Desk

NCT00872989 · Interventional trial

S0904: Docetaxel With or Without Vandetanib in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Overall registry status Completed

Phase 2

Conditions Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov